From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...

PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) recently submitted an updated Phase 2 clinical study design to the U.S.

In a study of mice exposed to thiacloprid and their offspring, increased risks for adverse impacts to prostate health are determined.

New technology designed to provide a single irrigation management system for ureteroscopy, cystoscopy, percutaneous ...

Waking once during the night to pass urine is fairly common. For many adults, particularly as they get older, this may happen ...

If urinary symptoms are affecting you, consult a urologist to explore advanced, minimally invasive treatments like Prostatic Urethral Lift (UroLift). Today's BPH treatments are designed to relieve ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for ...

The Asurys system is the latest addition to Boston Scientific’s StoneSmart Solutions product ecosystem.

NAVER D2SF, the corporate venture capital arm of NAVER, has made a follow-on investment in Soundable Health, a health tech startup leveraging AI-powered acoustic analysis to enable clinical-grade ...

Lifestyle factors such as smoking, alcohol consumption, obesity, and occupational exposures may also increase risk and influence screening choices.

PROCEPT BioRobotics trades at 2.9x forward EV/2026E revenue, a deep discount to peers, despite 27-33% guided revenue growth. Learn why PRCT stock is a buy.